Shots: NCCN and Pfizer have issued an open RFP that develop and validate enduring approaches to improve the safe, effective, and efficient adoption of biosimilars in oncology The RFP supports approaches to improve the processes related to biosimilar adoption in oncology. Letters of Intent are welcome from academic or community centers, patient advocacy groups and […]Read More
Shots: Roche signs a 15yrs. non-exclusive agreement with Illumina, allowing patients to access next-generation sequencing (NGS) based testing in oncology Roche to get right to develop & commercialize AVENIO IVD tests for both tissue and blood to be used on Illumina’s NextSeq 550Dx System while Illumina will continue to commercialize its NextSeq 550Dx Systems and […]Read More
Shots: Medtronic to distribute Viz.ai’s LVO detection and triage software services to ~200 hospitals with the goal of making Viz.ai available to every stroke center in the US The focus of the collaboration is to accelerate the adoption of Viz.ai’s technology to synchronize stroke care & decrease treatment time for improving QoL Viz.ai’s Viz LVO […]Read More
Copyright ©2021 PharmaShots | Powered by Octavus Consulting
